DLB
Dolby Laboratories, Inc.
DLB has slightly lower modeled downside risk, despite its lower overall score.
PLTR
Palantir Technologies Inc.
PLTR has the edge over DLB overall, supported by stronger fundamentals and stronger modeled upside.
DLB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
DLB's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
PLTR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
PLTR's revenue, profitability, cash flow and balance sheet are all currently strong.
DLB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $64.59 | — |
| Cheap | 27x | $62.50 | -3.2% |
| Current | 28x | $64.59 | — |
| Fair | 32x | $74.76 | +16% |
| Expensive | 40x | $94.26 | +46% |
Historical ranges are pointers, not guarantees.
DLB's PE is in its cheap range at 28x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
PLTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 75x | $172 | — |
| Current | 120x | $172 | — |
| Cheap | 165x | $236 | +37% |
| Fair | 251x | $359 | +109% |
| Expensive | 452x | $646 | +277% |
Historical ranges are pointers, not guarantees.
PLTR has the edge over DLB in the historical PE scenario, which offers more potential upside but is not a forecast.
DLB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect DLB's earnings to grow and its profitability to improve, with its revenue holding steady.
PLTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
PLTR has the edge over DLB on the outlook, with more favorable revenue expectations.
DLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.58 | +96% |
| Q2 2026 | $2.34 | -14% |
| Q1 2026 | $2.52 | -4.2% |
| Q4 2025 | $2.47 | -8.5% |
| Q3 2025 | $2.62 | -2.6% |
| Q2 2025 | $2.71 | +24% |
| Q1 2025 | $2.63 | +35% |
| Q4 2024 | $2.70 | +41% |
| Q3 2024 | $2.69 | +31% |
DLB earned $2.34 per share over the past year, down 14% from the year before.
PLTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.30 | +61% |
| Q3 2026 | $1.43 | +240% |
| Q2 2026 | $1.17 | +290% |
| Q1 2026 | $0.89 | +287% |
| Q4 2025 | $0.63 | +232% |
| Q3 2025 | $0.42 | +110% |
| Q2 2025 | $0.30 | +76% |
| Q1 2025 | $0.23 | +92% |
| Q4 2024 | $0.19 | +111% |
PLTR has the edge over DLB on earnings, with more consistent year-over-year improvement.
DLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $305M | -3.3% |
| Q1 2026 | $395.6M | +7.1% |
| Q4 2025 | $346.7M | -2.9% |
| Q3 2025 | $307M | +0.7% |
| Q2 2025 | $315.5M | +9.3% |
| Q1 2025 | $369.6M | +1.4% |
| Q4 2024 | $357M | +13% |
| Q3 2024 | $304.8M | +4.9% |
DLB's revenue grew through 2023 and has held roughly level since: $305M last quarter, down 3.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 11% | -3.8 points |
| Q1 2026 | 29% | -0.6 points |
| Q4 2025 | 18% | -4.4 points |
| Q3 2025 | 9.7% | -5.5 points |
| Q2 2025 | 15% | +2.4 points |
| Q1 2025 | 29% | -0.7 points |
| Q4 2024 | 22% | +1.4 points |
| Q3 2024 | 15% | +16 points |
DLB's operating margin was 11% last quarter, down 3.8 points from the same quarter a year ago.
PLTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.3B | +96% |
| Q2 2026 | $1.9B | +93% |
| Q1 2026 | $1.6B | +85% |
| Q4 2025 | $1.4B | +70% |
| Q3 2025 | $1.2B | +63% |
| Q2 2025 | $1B | +48% |
| Q1 2025 | $883.9M | +39% |
| Q4 2024 | $827.5M | +36% |
PLTR has the edge over DLB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +14 points |
| Q2 2026 | 47% | +20 points |
| Q1 2026 | 46% | +26 points |
| Q4 2025 | 41% | +40 points |
| Q3 2025 | 33% | +18 points |
| Q2 2025 | 27% | +11 points |
| Q1 2025 | 20% | +7.2 points |
| Q4 2024 | 1.3% | -9.5 points |
PLTR has the edge over DLB on profitability, with a higher operating margin.
DLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $152.5M | +149% |
| Q1 2026 | $83.4M | -50% |
| Q4 2025 | $50.2M | -50% |
| Q3 2025 | $106.6M | -2% |
| Q2 2025 | $61.3M | +349% |
| Q1 2025 | $168M | -2.6% |
| Q4 2024 | $100M | +4229% |
| Q3 2024 | $108.8M | +42% |
DLB's free cash flow has been positive every quarter for seven years: $393M over the past year, down 10% from the year before.
PLTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +139% |
| Q2 2026 | $1.2B | +126% |
| Q1 2026 | $891.8M | +193% |
| Q4 2025 | $764M | +67% |
| Q3 2025 | $500.9M | +20% |
| Q2 2025 | $531.6M | +276% |
| Q1 2025 | $304.1M | +140% |
| Q4 2024 | $457.2M | +54% |
PLTR has the edge over DLB on cash flow, with more consistent year-over-year improvement.
DLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -997K shares |
| 1 year | -2.5% | -2.4M shares |
| 3 years | -3% | -2.9M shares |
| 5 years | -9.7% | -10.1M shares |
| Available history | -8.2% | -8.4M shares |
DLB has the edge over PLTR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $65M |
| Q1 2026 | $65M |
| Q4 2025 | $70M |
| Q3 2025 | $35M |
| Q2 2025 | $40M |
| Q1 2025 | $35M |
| Q4 2024 | $15M |
| Q3 2024 | $20M |
DLB spent $235M buying back its own shares over the past year, up 114% from the year before.
PLTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +5.2M shares |
| 1 year | +0.1% | +2.9M shares |
| 3 years | +11% | +248M shares |
| 5 years | +31% | +610M shares |
| Available history | +184% | +1.7B shares |
PLTR has 2.6B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $19.2M |
| Q3 2025 | $19.2M |
| Q2 2025 | $18.6M |
| Q1 2025 | $18M |
| Q4 2024 | $18.6M |
| Q3 2024 | $18.9M |
| Q2 2024 | $17.7M |
| Q1 2024 | $9M |
DLB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -2.0x | Net Cash |
| Q1 2026 | -1.7x | Net Cash |
| Q4 2025 | -1.9x | Net Cash |
| Q3 2025 | -2.0x | Net Cash |
| Q2 2025 | -1.9x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.5x | Net Cash |
| Q3 2024 | -1.4x | Net Cash |
DLB has the edge over PLTR on leverage, with a lower net debt burden relative to earnings.
PLTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.9x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q1 2025 | -2.3x | Net Cash |
| Q4 2024 | -6.1x | Net Cash |
PLTR has more cash than debt.
DLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.5 | Neutral |
| Stochastic | 78.1 | Neutral |
DLB's weekly RSI is 58 (neutral) and its Stochastic is 78 (neutral).
PLTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 47.4 | Neutral |
PLTR's weekly RSI is 51 (neutral) and its Stochastic is 47 (neutral).
DLB PE vs Technology Sector
| Metric | DLB | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 28x | 0.9% below |
| PE % | 22 | 35 | 13 pts below |
DLB has the edge over PLTR on valuation relative to its sector.
PLTR PE vs Technology Sector
| Metric | PLTR | Sector median | Relative |
|---|---|---|---|
| PE | 120x | 28x | 331% above |
| PE % | 1 | 38 | 37 pts below |
PLTR is trading at 120x earnings, a 331% premium to the Technology sector's median of 28x.
DLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.3 | 5.4% above |
| 20 week MA | $59.2 | 9.1% above |
| 50 week MA | $60.3 | 7.1% above |
| 100 week MA | $67.5 | 4.4% below |
| 200 week MA | $74.3 | 13% below |
DLB has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 13% below its 200-week average.
PLTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $185.8 | 7.6% below |
| 20 week MA | $167.6 | 2.4% above |
| 50 week MA | $157.1 | 9.2% above |
| 100 week MA | $143.8 | 19% above |
| 200 week MA | $83.3 | 106% above |
PLTR has the edge over DLB on trend strength, trading above more of its moving averages.
DLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $68.3 | $95.3 | +39% |
| 2021 | $95.3 | $92.7 | -2.7% |
| 2022 | $92.7 | $69.2 | -25% |
| 2023 | $69.2 | $86.2 | +24% |
| 2024 | $86.2 | $78.5 | -8.9% |
| 2025 | $78.5 | $65.7 | -16% |
| 2026 YTD | $65.7 | $64.6 | -1.7% |
DLB has the edge over PLTR on returns for 2026, with the stronger performance.
PLTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.20 | $27.8 | +202% |
| 2021 | $27.8 | $18.9 | -32% |
| 2022 | $18.9 | $6.29 | -67% |
| 2023 | $6.29 | $17.2 | +173% |
| 2024 | $17.2 | $79.1 | +361% |
| 2025 | $79.1 | $188.7 | +139% |
| 2026 YTD | $188.7 | $171.6 | -9.1% |
PLTR's yearly returns have swung widely, from +361% in 2024 to −67% in 2022. It's down 9.1% so far in 2026.